Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.9 HKD | -0.62% | -1.07% | -56.42% |
Business Summary
Number of employees: 12,740
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Research Services on Fee-for-Service
83.6
%
| 9,684 | 78.1 % | 14,838 | 83.6 % | +53.22% |
Biologics Product
14.5
%
| - | - | 2,582 | 14.5 % | - |
Research Services on Full-Time-Equivalent
1.7
%
| 290 | 2.3 % | 309 | 1.7 % | +6.56% |
Project Management Organization Services
0.1
%
| 22 | 0.2 % | 26 | 0.1 % | +20.48% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
55.6
%
| 6,302 | 50.8 % | 9,880 | 55.6 % | +56.78% |
China
24.4
%
| 3,026 | 24.4 % | 4,325 | 24.4 % | +42.92% |
Europe
16.7
%
| 2,743 | 22.1 % | 2,961 | 16.7 % | +7.93% |
Rest of the World
3.3
%
| 330 | 2.7 % | 590 | 3.3 % | +78.45% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 11-05-31 |
Ming Tu
DFI | Director of Finance/CFO | 54 | 21-08-22 |
Gu Jijie
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Weichang Zhou
BRD | Director/Board Member | 59 | 12-11-30 |
Yue Huang
SEC | Corporate Secretary | - | 18-11-19 |
Ying Man Sham
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jackson Tai
BRD | Director/Board Member | 73 | 23-05-05 |
William Keller
BRD | Director/Board Member | 75 | 17-05-16 |
Ge Li
CHM | Chairman | 56 | 10-04-30 |
Yan Ling Cao
BRD | Director/Board Member | 39 | 16-04-30 |
Yi Bing Wu
BRD | Director/Board Member | 55 | 16-04-30 |
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 11-05-31 |
Weichang Zhou
BRD | Director/Board Member | 59 | 12-11-30 |
Kenneth Hitchner
BRD | Director/Board Member | 63 | 20-06-08 |
Jue Chen
BRD | Director/Board Member | 54 | 23-08-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,259,278,169 | 3,655,307,975 ( 85.82 %) | 0 | 85.82 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
WuXi Biologics (Hong Kong) Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.42% | 6.9B | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- 2269 Stock
- Company WuXi Biologics (Cayman) Inc.